Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT05774951

1 development in the corpus

NCT05774951

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 19, 2026 · PHASE 3 TRIAL

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

ClinicalTrials.gov

This is an active Phase 3 trial registration with no reported results; the study design and primary endpoint are specified but outcome data are not yet available.

PreliminaryCamizestrant Breast Cancer, Early Breast Cancer Letrozole

Reported

Planned enrollment4300

Study phasePhase 3

Primary outcome measureInvasive breast cancer-free survival (IBCFS…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support